IP Library Assignment 042285/0747
Patent Assignment
Reel/Frame 042285/0747

Assignment of Assignor's Interest

Recorded: 2017-04-20 Pages: 6
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-07-09
DUFFY, BRYAN CORDELL
Executed: 2013-07-12
LIU, SHUANG
Executed: 2013-07-12
WANG, RUIFANG
Executed: 2013-07-12
JIANG, MAY XIAOWU
Executed: 2013-07-12
MARTIN, GREGORY SCOTT
Executed: 2013-07-12
WAGNER, GREGORY STEVEN
Executed: 2013-07-26
YOUNG, PETER RONALD
Executed: 2013-07-10
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Application: 15/486,256 →
Publication: US 2017/0216301
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2017
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 042285/0768 →
Assignment of Assignor's Interest Apr 21, 2017
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 042092/0756 →
General Conveyance and Assumption Agreement Apr 21, 2017
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 042310/0619 →
Change of Name Apr 21, 2017
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 042310/0644 →